Total Payments
$12,720
2024 Payments
$2,373
Companies
36
Transactions
498
Medicare Patients
24,779
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$8,157 (64.1%)
Travel$3,641 (28.6%)
Research$700.00 (5.5%)
Education$222.33 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,157 | 471 | 64.1% |
| Travel and Lodging | $3,641 | 16 | 28.6% |
| Unspecified | $700.00 | 5 | 5.5% |
| Education | $222.33 | 6 | 1.7% |
Payments by Type
General
$12,020
493 transactions
Research
$700.00
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $8,031 | 213 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $780.83 | 73 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $605.18 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $411.86 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $401.28 | 18 | $0 (2024) |
| Edwards Lifesciences Corporation | $320.66 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $305.17 | 21 | $0 (2024) |
| United Therapeutics Corporation | $258.97 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $231.16 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $198.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,373 | 104 | Abbott Laboratories ($1,601) |
| 2023 | $3,208 | 92 | Abbott Laboratories ($2,212) |
| 2022 | $3,535 | 111 | Abbott Laboratories ($2,527) |
| 2021 | $793.01 | 49 | Abbott Laboratories ($188.30) |
| 2020 | $404.44 | 31 | Abbott Laboratories ($182.84) |
| 2019 | $773.83 | 34 | Abbott Laboratories ($296.86) |
| 2018 | $760.51 | 45 | Abbott Laboratories ($442.53) |
| 2017 | $872.63 | 32 | Abbott Laboratories ($581.36) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $65.07 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Structural Heart | ||||||
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Structural Heart | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/04/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Structural Heart | ||||||
| 11/22/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Structural Heart | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Not Applicable | ||||||
| 11/11/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/11/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Structural Heart | ||||||
| 11/06/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Structural Heart | ||||||
| 11/05/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/05/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/05/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/24/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Structural Heart | ||||||
| 10/17/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiac Rhythm Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OPTIMUM Lead Registry | Abbott Laboratories | $400.00 | 2 |
| Optim Lead Insulation Material (OPTIMUM) Registry | Abbott Laboratories | $300.00 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,888 | 15,963 | $1.2M | $367,662 |
| 2022 | 44 | 6,886 | 10,106 | $1.2M | $356,439 |
| 2021 | 43 | 6,106 | 8,897 | $1.1M | $344,532 |
| 2020 | 43 | 5,899 | 7,886 | $966,211 | $299,576 |
Total Patients
24,779
Total Services
42,852
Medicare Billing
$1.4M
Procedure Codes
185
All Medicare Procedures & Services
185 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,046 | 1,667 | $243,116 | $131,722 | 54.2% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 14 | 7,100 | $162,656 | $66,904 | 41.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 251 | $26,491 | $15,011 | 56.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 31 | 38 | $47,412 | $14,417 | 30.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 310 | 314 | $57,144 | $13,880 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,145 | 1,474 | $92,848 | $13,600 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $26,819 | $11,951 | 44.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 213 | 217 | $64,986 | $10,815 | 16.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 32 | 170 | $20,482 | $8,759 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 151 | $15,005 | $7,911 | 52.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,113 | 1,438 | $19,768 | $7,910 | 40.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 43 | 43 | $103,287 | $7,218 | 7.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 52 | 938 | $64,680 | $7,078 | 10.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 121 | 122 | $37,086 | $6,904 | 18.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 213 | 217 | $14,873 | $5,325 | 35.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 51 | $10,989 | $4,827 | 43.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 84 | 180 | $18,777 | $3,322 | 17.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 115 | 242 | $25,244 | $3,122 | 12.4% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 11 | 12 | $34,056 | $2,854 | 8.4% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 29 | 155 | $8,174 | $2,581 | 31.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 41 | 67 | $4,391 | $2,523 | 57.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 130 | 134 | $15,322 | $2,057 | 13.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 66 | 76 | $10,308 | $1,954 | 19.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 30 | 31 | $9,390 | $1,729 | 18.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 32 | 63 | $9,905 | $1,483 | 15.0% |
About Dr. David Law, MD
Dr. David Law, MD is a Interventional Cardiology healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285670596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Law, MD has received a total of $12,720 in payments from pharmaceutical and medical device companies, with $2,373 received in 2024. These payments were reported across 498 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,157).
As a Medicare-enrolled provider, Law has provided services to 24,779 Medicare beneficiaries, totaling 42,852 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 185 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Cape Girardeau, MO
- Active Since 06/22/2006
- Last Updated 07/26/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1285670596
Products in Payments
- AVEIR (Device) $3,553
- AMPLATZER AMULET (Device) $2,249
- XARELTO (Drug) $780.83
- LifeVest (Device) $605.18
- JARDIANCE (Drug) $401.28
- CRM-Research only (Device) $400.00
- Assurity Pacemaker (Device) $372.08
- Optim ICD (Device) $300.00
- VERQUVO (Drug) $291.01
- LEQVIO (Drug) $251.64
- DUPIXENT (Biological) $218.71
- QUADRA ASSURA (Device) $217.17
- Quadra Assura CRT Defibrillator (Device) $204.78
- ENTRESTO (Drug) $160.22
- Pacemakers (Device) $138.16
- ORENITRAM (Drug) $133.62
- TYVASO (Drug) $125.35
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $115.27
- Arcalyst (Drug) $105.03
- Barostim Neo System (Device) $96.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Cape Girardeau
Clifford Talbert, Md, MD
Interventional Cardiology — Payments: $7,394
Interventional Cardiology $7,394
William Lafoe, Md, MD
Interventional Cardiology — Payments: $6,772
Interventional Cardiology $6,772
Kenneth Retter, Md, MD
Interventional Cardiology — Payments: $4,517
Interventional Cardiology $4,517
Dr. Ali Farooq, M.d.,, M.D.,
Interventional Cardiology — Payments: $3,581
Interventional Cardiology $3,581
Allen Spitler, Md, MD
Interventional Cardiology
Interventional Cardiology